Overweight

Showing NaN - NaN of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Not yet recruiting
  • Obesity
  • Overweight
  • Decatur, Georgia
  • +35 more
Oct 11, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Pelham, Alabama
  • +135 more
May 15, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

ReNEW Clinic Cohort Study

Recruiting
  • Hypertension
  • +5 more
    • Baltimore, Maryland
      Johns Hopkins University
    Jan 13, 2023

    Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

    Active, not recruiting
    • Overweight
    • Obesity
    • Birmingham, Alabama
    • +804 more
    Dec 19, 2022

    Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

    Active, not recruiting
    • Type 2 Diabetes
    • +2 more
    • Birmingham, Alabama
    • +74 more
    Apr 18, 2022

    Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • +4 more
    • Lifestyle Intervention
    • Birmingham, Alabama
    • +38 more
    Mar 10, 2022

    PreDiabetes, Hyperglycemia, Glucose, High Blood Trial in Baltimore, Reading (Digital Diabetes Prevention Program (dDPP), Human

    Recruiting
    • PreDiabetes
    • +10 more
    • Digital Diabetes Prevention Program (dDPP)
    • Human Coach-based Diabetes Prevention Program (hDPP)
    • Baltimore, Maryland
    • +1 more
    Mar 28, 2022

    Overweight Trial in Baltimore, San Antonio (Weight Maintenance, Weight Maintenance + Intermittent Fasting)

    Recruiting
    • Overweight
    • Weight Maintenance
    • Weight Maintenance + Intermittent Fasting
    • Baltimore, Maryland
    • +1 more
    Feb 9, 2022

    Diabetes, Diabetes, Type 2, PreDiabetes Trial in Baltimore (The Diabetes Prevention Program)

    Enrolling by invitation
    • Diabetes Mellitus
    • +9 more
    • The Diabetes Prevention Program
    • Baltimore, Maryland
      Johns Hopkins School of Nursing
    Dec 9, 2021

    ORBERA™ Post-Approval Study

    Completed
    • Obesity
    • Overweight
      • Little Rock, Arkansas
      • +10 more
      Jul 9, 2020

      Overweight, Obesity, Depression Trial in Baltimore (Maternal Physical Activity and Nutrition, Parenting, Child Safety)

      Completed
      • Overweight
      • +2 more
      • Maternal Physical Activity and Nutrition
      • +2 more
      • Baltimore, Maryland
      • +1 more
      May 4, 2020

      Hypertension, Prehypertension, Overweight Trial in Baltimore (Electronic Media Application, Standard of care education)

      Completed
      • Hypertension
      • +4 more
      • Electronic Media Application
      • Standard of care education
      • Baltimore, Maryland
        Johns Hopkins University
      Mar 11, 2020

      Obesity, Overweight Trial in Worldwide (LIK066, Placebo)

      Completed
      • Obesity
      • Overweight
      • Anniston, Alabama
      • +82 more
      Jan 27, 2020

      Overweight, Obesity Trial in Baltimore (Challenge! Small Group Intervention, Challenge! Environmental Intervention)

      Completed
      • Overweight
      • Obesity
      • Challenge! Small Group Intervention
      • Challenge! Environmental Intervention
      • Baltimore, Maryland
        Baltimore City Public Schools
      Aug 14, 2019

      Overweight Trial in Baltimore (Challenge!)

      Completed
      • Overweight
      • Challenge!
      • Baltimore, Maryland
        University of Maryland School of Medicine
      Aug 14, 2019

      Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

      Completed
      • Cardiovascular Disease
      • +4 more
      • Lorcaserin hydrochloride
      • Placebo
      • Alexander City, Alabama
      • +498 more
      Jun 27, 2019

      Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

      Terminated
      • Obesity
      • Overweight
      • Birmingham, Alabama
      • +223 more
      Feb 24, 2017

      Overweight, Cardiovascular Diseases Trial in Baltimore, Boston (High carbohydrate and low glycemic index (GI) diet, Low

      Completed
      • Overweight
      • Cardiovascular Diseases
      • High carbohydrate and low glycemic index (GI) diet
      • +3 more
      • Baltimore, Maryland
      • +1 more
      Jul 5, 2016

      Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary

      Completed
      • Obesity
      • +2 more
      • Naltrexone SR 32 mg/bupropion SR 360 mg/ day
      • +2 more
      • Fairhope, Alabama
      • +52 more
      Nov 18, 2014

      Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360

      Completed
      • Obesity
      • Overweight
      • Naltrexone SR 16 mg/Bupropion SR 360 mg /day
      • +3 more
      • Birmingham, Alabama
      • +33 more
      Nov 18, 2014

      Overweight, Obesity, Type 2 Diabetes Trial in Baltimore (Weight loss diet, Weight loss diet plus exercise)

      Completed
      • Overweight
      • +3 more
      • Weight loss diet
      • Weight loss diet plus exercise
      • Baltimore, Maryland
        Johns Hopkins Bayview Medical Center
      Apr 1, 2013

      Overweight, Obese, Sedentary Trial in Baltimore (Weight Loss Diets Plus Exercise)

      Completed
      • Overweight
      • +3 more
      • Weight Loss Diets Plus Exercise
      • Baltimore, Maryland
        Johns Hopkins Bayview Medical Center
      Apr 1, 2013

      Overweight, Obesity Trial in Baltimore (lifestyle intervention)

      Completed
      • Overweight
      • Obesity
      • lifestyle intervention
      • Baltimore, Maryland
        Johns Hopkins School of Medicine
      Jun 18, 2009